Abstract:Context: The study was designed to evaluate the effect of a hypofractionated, palliative conformal radiotherapy regimen of 5250 cGy in 15 fractions in inoperable/incurable oral cavity carcinoma. Aims: The primary objective was to assess the change in the quality of life (QOL) with respect to pain and mouth opening pre- and post-radiotherapy using standardized questionnaires. The secondary objective was to assess overall QOL using the same questionnaires and also to assess response rates, survival, compliance, early and late toxicity. Settings and Design: This was a single-arm, prospective trial. Patients with incurable oral cavity cancer referred for palliative intent radiotherapy to the Department of Radiotherapy, RCC, JIPMER were recruited into the study. Subjects and Methods: Forty-eight patients were recruited and twenty-five patients were given conformal radiotherapy to a dose of 52.5 Gy in 15 fractions. QOL was assessed using the European Organization of Research and Treatment of Cancer (EORTC) questionnaires before and 2 months after the completion of radiotherapy. The response assessment was made using the Response Evaluation Criteria in Solid Tumors (RECIST) criteria 2 months after radiotherapy. The early and late toxicities were assessed at 2 months and 6 months after radiotherapy completion, respectively. Statistical Analysis Used: Sample size was calculated to be 53. The Wilcoxon signed-rank test was used to compare QOL scores pre- and post-radiotherapy. Median survival was assessed using the Kaplan–Meier method. Results: There was a significant improvement in the pain, mouth opening, speech, social contact, social eating, felt ill items of the EORTC QLQ-H and N35 questionnaire and role functioning, emotional functioning, social functioning, fatigue, pain, insomnia, appetite loss, financial difficulties, and Global QOL subscales of the QLQ-C30 questionnaire. 72% of the patients had grade 3 acute radiation oral mucositis and 36% had grade 3 acute radiation dermatitis. There were no significant treatment breaks due to toxicity. There were no grade 3 late toxicities observed. Overall median survival was 5.1 months. The overall response rate was 47%. The median time to treatment completion was 24 days. Conclusions: The improvement in QOL parameters suggests that the regimen of 52.5 Gy in 15 fractions is suitable for palliative intent radiotherapy in late-stage oral cavity cancer for effective palliation for short periods.

Radiotherapy In The Head And Neck Region In Childhood And Adolescence: Late Oral Complications And Quality Of Life

Comparison of Quality of Life in Patients with Nasopharyngeal Carcinoma Receiving Conventional External Beam Radiation Therapy Versus Intensity Modulated Radiation Therapy

Late Oral Complications Following Radiotherapy for Head and Neck Cancers

Clinical Analysis of Radiotherapy for Nasopharyngeal Carcinoma in 145 Children and Adolescents

Late dental and bone alterations in patients after orbital rhabdomyosarcoma treatment

Oral Soft-Tissue Necrosis Following Radiotherapy: A Case Series

Bone age and dental late effects in childhood cancer survivors: Radiographic findings in a Brazilian sample

The spectrum of late radiation sequelae in head and neck cancer

Investigation and Analysis of Late Complications of 96 Patients with Nasopharyngeal Carcinoma treated by Radiotherapy

Limitation of mouth opening after radiotherapy for head and neck

Progress of Oral Sequelae During Head-Neck Radiotherapy.

Late Toxicities after Conventional Radiotherapy for Nasopharyngeal Carcinoma: Incidence and Risk Factors

Systemic sequelae and craniofacial development in survivors of pediatric rhabdomyosarcoma

Effect of hypofractionated, palliative radiotherapy on quality of life in late-stage oral cavity cancer: A prospective clinical trial

Dental Care in Head and Neck Cancer Patients Undergoing Radiotherapy

Dental management before radiotherapy of the head and neck region: 4‐year single‐center experience

Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis

Patient‐reported outcomes for dental health, shoulder‐neck dysfunction, and overall quality of life after treatment with radiation for head and neck cancer

A prospective study on oral adverse effects in head and neck cancer patients submitted to a preventive oral care protocol

Risk-Stratified Radiotherapy in Pediatric Cancer

Dental Sequelae Of Oncological Treatment For Rhabdomyosarcoma On An Infant Patient.